NDC 0074-7096 – Qulipta
Atogepant 30 mg/1 · Tablet · Oral
Product NDC0074-7096
Product details
- Brand name
- Qulipta
- Generic name
- Atogepant
- Labeler
- AbbVie Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA215206
- Marketed since
- September 30, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Calcitonin Gene-related Peptide Receptor Antagonist
Active ingredients
- Atogepant 30 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0074-7096-04 sample | 4 TABLET in 1 BOTTLE (0074-7096-04) | Oct 6, 2021 |
| 0074-7096-30 | 30 TABLET in 1 BOTTLE (0074-7096-30) | Sep 30, 2021 |
| 0074-7096-70 sample | 4 TABLET in 1 BOTTLE (0074-7096-70) | Feb 6, 2026 |